LONG BEACH, California — An experimental new gene therapy has specialists questioning whether heart vessel growth to restore blood flow could actually be possible in refractory angina after ...

If you have a history of heart failure. If you have any problems with the way your liver works. If you have ever had a heart attack. If you have ever had an allergic reaction to a medicine. This ...

The arrest of individuals for promoting stents in cardiac patients highlights the critical issue of overuse of stents. Learn about the impact of unnecessary stenting and the importance of using stents ...

XyloCor Therapeutics, Inc. recently revealed the final results from the Phase 2 segment of its EXACT clinical trial at the ...

Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor ...

XC001 is designed to transiently grow new blood vessels to restore blood flow in the heart. It contains alternative splicing of the three isoforms of VEGF-A, which sets it apart from past attempts at ...

Millions rely on medication to manage their health. Whether it’s a quick prescription to treat an illness or a long-term ...

For a substantial portion of patients experiencing long COVID and new-onset chest pain, ischemia with nonobstructive coronary arteries (INOCA) appears to be the underlying cause of their angina, ...

But just last week, another TMZ case surfaced regarding Olympic refugee team runner Anjelina Nadai Lohalith, who also was ...

SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...

Anjelina Nadai Lohalith, who ran as a refugee athlete in the 1,500 metres at the 2016 and 2021 Olympics, has been suspended ...